Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41).

BACKGROUND The aim of this study was to evaluate the association of polymorphisms of the peroxisome proliferator-activated receptor gamma (PPARG) gene and peroxisome proliferators-activated receptor gamma co-activator 1 alpha (PPARGC1A) gene with diabetic nephropathy (DN) in Asian Indians. METHODS Six common polymorphisms, 3 of the PPARG gene [-1279G/A, Pro12Ala, and His478His (C/T)] and 3 of the PPARGC1A gene (Thr394Thr, Gly482Ser, and +A2962G) were studied in 571 normal glucose-tolerant (NGT) subjects, 255 type 2 diabetic (T2D) subjects without nephropathy, and 141 DN subjects. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing. Logistic regression analysis was performed to assess the covariables associated with DN. RESULTS Among the 6 polymorphisms examined, only the Gly482Ser of the PPARGC1A gene was significantly associated with DN. The genotype frequency of Ser/Ser genotype of the PPARGC1A gene was 8.8% (50/571) in NGT subjects, 7.8% (20/255) in T2D subjects, and 29.8% (42/141) in DN subjects. The odds ratios (ORs) for DN for the susceptible Gly/Ser and Ser/Ser genotype after adjusting for age, sex, body mass index, and duration of diabetes were 2.14 [95% confidence interval (CI), 1.23-3.72; P = 0.007] and 8.01 (95% CI, 3.89-16.47; P < 0.001), respectively. The unadjusted OR for DN for the XA genotype of the Thr394Thr polymorphism was 1.87 (95% CI, 1.20-2.92; P = 0.006) compared to T2D subjects. However, the significance was lost (P = 0.061) when adjusted for age, sex, BMI, and duration of diabetes. The +A2962G of PPARGC1A and the 3 polymorphisms of PPARG were not associated with DN. CONCLUSION The Gly482Ser polymorphism of the PPARGC1A gene is associated with DN in Asian Indians.

[1]  Rajeev Gupta,et al.  Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes , 2008, BMC Genetics.

[2]  D. Bowden,et al.  Genetic factors in diabetic nephropathy. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[3]  V. Mohan,et al.  Prevalence and Risk Factors of Diabetic Nephropathy in an Urban South Indian Population , 2007, Diabetes Care.

[4]  V. Mohan,et al.  Absence of Association of Metabolic Syndrome with PPARGC1A, PPARG and UCP1 Gene Polymorphisms in Asian Indians. , 2007, Metabolic syndrome and related disorders.

[5]  R. Elston,et al.  Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations , 2007, Diabetes.

[6]  Huiyun Liang,et al.  Staying Current PGC-1 : a key regulator of energy metabolism , 2006 .

[7]  V. Mohan,et al.  Role of Genetic Polymorphism Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala on Ethnic Susceptibility to Diabetes in South-Asian and Caucasian Subjects , 2006, Diabetes Care.

[8]  V. Mohan,et al.  Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. , 2006, Diabetes care.

[9]  Rajeev Gupta,et al.  Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms , 2006, BMC Medical Genetics.

[10]  V. Mohan,et al.  Peroxisome proliferator‐activated receptor‐γ co‐activator‐1α (PGC‐1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[11]  S. Sookoian,et al.  Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. , 2005, Journal of molecular endocrinology.

[12]  M. Hirata,et al.  Association between Pro12Ala polymorphism of the PPAR‐γ2 gene and insulin sensitivity in Brazilian patients with type‐2 diabetes mellitus , 2005, Diabetes, obesity & metabolism.

[13]  T. Hansen,et al.  PGC-1α Gly482Ser Polymorphism Associates With Hypertension Among Danish Whites , 2005 .

[14]  C. Bellanné-Chantelot,et al.  The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-γ coactivator-1 gene is associated with hypertension in type 2 diabetic men , 2004, Diabetologia.

[15]  B. Salako,et al.  Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. , 2004, Journal of the National Medical Association.

[16]  M. Molitch.  How long should insulin be used once a vial is started? , 2004, Diabetes care.

[17]  T. Kunej,et al.  A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. , 2004, Folia biologica.

[18]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[19]  P. Majumder,et al.  Ethnic India: a genomic view, with special reference to peopling and structure. , 2003, Genome research.

[20]  V. Mohan,et al.  The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). , 2003, The Journal of the Association of Physicians of India.

[21]  J. Staessen,et al.  Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. , 2002, Diabetes.

[22]  R. Breyer,et al.  Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature , 2001 .

[23]  L. Wasserman,et al.  Genomic control, a new approach to genetic-based association studies. , 2001, Theoretical population biology.

[24]  R. Cantor,et al.  Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p , 2001, Hypertension.

[25]  Ambady Ramachandran,et al.  Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. , 2001, JOP : Journal of the pancreas.

[26]  R. Breyer,et al.  Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. , 2001, American journal of physiology. Renal physiology.

[27]  D. Moczulski,et al.  Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. , 1998, Diabetes.

[28]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[29]  M. Ehm,et al.  An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. , 1998, The Journal of clinical investigation.

[30]  K. Silver,et al.  Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation , 1997 .

[31]  K. Silver,et al.  Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. , 1997, Biochemical and biophysical research communications.

[32]  R. Graves,et al.  Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma , 1996, Molecular and cellular biology.

[33]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .